Related Experiment Video
Updated: Aug 8, 2025
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.6K
Myocarditis Following COVID-19 Vaccination
Constantin A Marschner1, Kirsten E Shaw2, Felipe Sanchez Tijmes3
1Department of Medical Imaging, Toronto General Hospital, Peter Munk Cardiac Center, University Health Network (UHN), University of Toronto, 1 PMB-298, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada; Department of Radiology, University Hospital, LMU Munich, Munich 81377, Germany.
Heart Failure Clinics
|March 2, 2023
Summary
Myocarditis is a rare side effect of COVID-19 vaccines, primarily affecting young males. While most cases show mild cardiac imaging changes and improve quickly, further research is needed on long-term outcomes.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- Messenger RNA (mRNA) vaccines for COVID-19 are widely used.
- Myocarditis is a known, though rare, adverse event associated with these vaccines.
- The condition predominantly affects adolescent and young adult males.
Purpose of the Study:
- To review the existing literature on myocarditis post-COVID-19 vaccination.
- To analyze incidence, risk factors, clinical presentation, and imaging findings.
- To explore potential pathophysiologic mechanisms and long-term implications.
Main Methods:
- Systematic literature review of studies on COVID-19 vaccine-associated myocarditis.
- Analysis of reported cases regarding demographics, symptom onset, and clinical course.
- Evaluation of cardiac imaging findings and treatment responses.
Main Results:
- Myocarditis following COVID-19 vaccination is rare but established.
- Onset typically occurs within days of vaccination, with a higher incidence in young males.
- Most patients exhibit mild cardiac imaging abnormalities and respond well to standard treatment.
Conclusions:
- While generally mild and treatable, long-term follow-up is crucial for vaccine-associated myocarditis.
- Further research should address persistent imaging abnormalities and risks of subsequent vaccination.
- Understanding pathophysiologic mechanisms is key for vaccine safety monitoring.
More Related Videos
Related Concept Videos
01:14Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
01:27Myocarditis II: Clinical Features and Diagnostic Tests
17
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
17
01:21Myocarditis I: Introduction
16
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
16
01:22Myocarditis IV: Nursing Management
17
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
01:22Pericarditis I: Introduction
15
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
15
01:17Pericarditis III: Medical Management
20
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
20